Bashar Ababneh, MD
Interventional Cardiology · Topeka, KSNPI 1790914521
Payments from drug & device makers
What this record shows
Medtronic accounts for 60.1% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $1,712 and has fallen 86.5% since, to $232 in 2025. That places this record below the midpoint for interventional cardiology clinicians in KS, where the typical reported total is $8,846.
Across 29 payments — averaging $83.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Abiomed$365
- Boston Scientific$258
- Abbott$128
- Shockwave Medical, Inc$109
- Cardiovascular Systems Inc.$38
- plus $69 from 3 others
What the payments were for
- Travel & lodging$1,13347%
- Food & beverage$1,28853%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 8 | $1,455 |
| Abiomed | 5 | $365 |
| Boston Scientific | 4 | $258 |
| Abbott | 2 | $128 |
| Shockwave Medical, Inc | 1 | $109 |
| Cardiovascular Systems Inc. | 5 | $38 |
| Bard Peripheral Vascular, Inc. | 1 | $25 |
| Cardinal Health 200 LLC | 2 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,421 in reported general payments places this provider in the 15th percentile of 55 interventional cardiology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 71 | $67,008 |
| Repatha SureclickEvolocumab | 15 | $11,809 |
| Cilostazol | 98 | $1,961 |
| ClopidogrelClopidogrel Bisulfate | 237 | $1,944 |
| Atorvastatin Calcium | 275 | $1,936 |
| Ezetimibe | 57 | $1,821 |
| Amlodipine Besylate | 251 | $1,509 |
| Metoprolol Succinate | 88 | $1,502 |
| Carvedilol | 127 | $906 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 90 | $769 |
| Metoprolol Tartrate | 119 | $580 |
| Losartan Potassium | 79 | $575 |
| Rosuvastatin Calcium | 51 | $462 |
| Lisinopril | 73 | $439 |
| Hydralazine Hcl | 40 | $356 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Topeka
- Ahmed SoukaTopeka$37K
- Sindhu AvulaTopeka$18K
- Seshu RaoTopeka$6K
- Jack JonesTopeka$3K
- Anthony SpaedyKansas City$385K
- Prasad GunasekaranKansas City$76K
- Maheedhar GedelaWichita$54K
- Kamal GuptaKansas City$46K
- Priyantha RanaweeraManhattan$41K
- Mark WileyKansas City$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.